COVID-19 National News

Ministries of education need to embed ongoing anti-racist training into their teacher education program, prof says

Johnson & Johnson announced promising results from its Phase 3 clinical trials at the end of January, suggesting its vaccine reduced severe COVID-19 disease by 85 per cent, and prevented 100 per cent of COVID-related hospitalization or death

It is the fourth vaccine to be approved in Canada and the first and only one Canada has purchased that requires just a single dose

Dr. Nitin Mohan, an epidemiologist and assistant professor at Western University, said switching the messaging to promote outdoor activities makes sense from a harm reduction standpoint

About $2.9 million will be spent on the research in British Columbia, Ontario, and Quebec as part of the work of the national COVID-19 immunity task force

A geriatrician at Sinai Health in Toronto said deaths that have been recorded as a result of COVID-19 only reflect those who were tested for it

Canada's authorized vaccines, Pfizer-BioNTech, Moderna and Oxford-AstraZeneca, all appear to have very good results against B.1.1.7, which is the most common variant so far found in Canada

The province said it will soon share details on an updated vaccine plan that accounts for the new dosing recommendation as well as expected supply of the recently approved Oxford-AstraZeneca shots

Tiny moments of playful connection can invite feelings of gratitude

By the time that dose is injected, it has travelled to at least six different cities in four countries, across the Atlantic Ocean twice, and monitored by a 24-hour watchtower in Iceland every step of the way